National Enzyme Company Overview
- Founded
- 1932

- Status
- Acquired/Merged
- Employees
- 130

- Latest Deal Type
- Buyout/LBO
- Financing Rounds
- 2
National Enzyme Company General Information
Description
Manufacturer of enzyme-based dietary supplements. The company offers a range of enzyme-based nutritional supplements to improve cognitive and sleep functions, digestive health, joint & bone functions, immunity, metabolism, weight management and women's health and provides product development, blending, encapsulating, tablet packing, convenience packaging, full-service bottling, graphics, labeling and fulfillment services, enabling client to gain a one-stop solution for all their contract manufacturing needs.
Contact Information
- 15366 U.S. Highway 160
- Forsyth, MO 65653
- United States
National Enzyme Company Valuation & Funding
Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
---|
This information is available in the PitchBook Platform. To explore National Enzyme Company‘s full profile, request access.
Request a free trialNational Enzyme Company Comparisons
Industry
00000000
00000000
PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.
Request a free trialNational Enzyme Company Competitors (3)
Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
---|---|---|---|---|---|---|
NutraScience Labs | Corporation | Farmingdale, NY | 00 | |||
00000000 | Corporation | Richardson, TX | 000000000 - | |||
00000000 00000 | Corporation | Gilbert, AZ | 000000000 - |
National Enzyme Company Patents
National Enzyme Company Recent Patent Activity
Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
---|---|---|---|---|---|
US-20080081035-A1 | Using aspergillus akaline protease as tool in treatment and prevention of infection, cardiovascular, rheumatic, soft tissue and skin disorders | Abandoned | 03-Oct-2006 | 00000000 | 0 |
US-20040191237-A1 | Mixture of proteases from aspergillus oryzae and bacillus subtilis and an aspergillus niger lipase; indigestion, sour stomach, dyspepsia, and other gastrointestinal disorders related to poor protein digestion | Granted | 28-Mar-2003 | 000000000 | 0 |
US-7067124-B2 | Mixture of aspergillus protease, bacillus protease and aspergillus lipase | Active | 28-Mar-2003 | 000000000 | 0 |
US-20080213241-A1 | Using mixture comprising microbial lipase and/or plant protease for enhancing digestion and treating gastrointestinal disorders | Abandoned | 28-Mar-2003 | 000000000 | 0 |
US-20040071685-A1 | Increasing conversion of glycolsylated isoflavone using con-current ingestion of digestive enzymes | Abandoned | 09-Oct-2002 | A61K38/47 | 00 |
National Enzyme Company Signals
Growth Rate

Growth

Size Multiple


Key Data Points
Twitter Followers
5.5k

Similarweb Unique Visitors
15.0K

Majestic Referring Domains
314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.
Request a free trialNational Enzyme Company Former Investors
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
---|
This information is available in the PitchBook Platform. To explore National Enzyme Company‘s full profile, request access.
Request a free trial